Nevanac
Loading...Nevanac Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
There is currently no warning information available for this product. We apologize for any inconvenience.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
NEVANAC® ophthalmic suspension is indicated for the treatment of pain and inflammation associated with cataract surgery.
History
There is currently no drug history available for this drug.
Other Information
NEVANAC® (nepafenac ophthalmic suspension) 0.1% is a sterile, topical, nonsteroidal anti-inflammatory (NSAID) prodrug for ophthalmic use. Each mL of NEVANAC® suspension contains 1 mg of nepafenac. Nepafenac is designated chemically as 2-amino-3-benzoylbenzeneacetamide with an empirical formula of C15H14N2O2. The structural formula of nepafenac is:
Nepafenac is a yellow crystalline powder. The molecular weight of nepafenac is 254.28. NEVANAC® ophthalmic suspension is supplied as a sterile, aqueous 0.1% suspension with a pH approximately of 7.4.
The osmolality of NEVANAC® ophthalmic suspension is approximately 305 mOsmol/kg.
Each mL of NEVANAC® contains: Active: nepafenac 0.1% Inactives: mannitol, carbomer 974P, sodium chloride, tyloxapol, edetate disodium, benzalkonium chloride 0.005% (preservative), sodium hydroxide and/or hydrochloric acid to adjust pH and purified water, USP.
Sources
Nevanac Manufacturers
-
Alcon Laboratories, Inc.
![Nevanac (Nepafenac) Suspension For Ophthalmic Use [Alcon Laboratories, Inc.]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Nevanac | Alcon Laboratories, Inc.
2.1 Recommended DosingOne drop of NEVANAC should be applied to the affected eye(s) three-times-daily beginning 1 day prior to cataract surgery, continued on the day of surgery and through the first 2 weeks of the postoperative period.
2.2 Use with Other Topical Ophthalmic MedicationsNEVANAC® may be administered in conjunction with other topical ophthalmic medications such as beta-blockers, carbonic anhydrase inhibitors, alpha-agonists, cycloplegics, and mydriatics.
-
Physicians Total Care, Inc.
Nevanac | Physicians Total Care, Inc.
Enter section text here
2.1 Recommended DosingOne drop of NEVANAC® should be applied to the affected eye(s) three-times-daily beginning 1 day prior to cataract surgery, continued on the day of surgery and through the first 2 weeks of the postoperative period.
2.2 Use with Other Topical Ophthalmic MedicationsNEVANAC® may be administered in conjunction with other topical ophthalmic medications such as beta-blockers, carbonic anhydrase inhibitors, alpha-agonists, cycloplegics, and mydriatics.
-
Alcon Laboratories, Inc.
Nevanac | Alcon Laboratories, Inc.
2.1 Recommended DosingOne drop of NEVANAC® should be applied to the affected eye three-times-daily beginning 1 day prior to cataract surgery, continued on the day of surgery and through the first 2 weeks of the postoperative period.
2.2 Use with Other Topical Ophthalmic MedicationsNEVANAC® may be administered in conjunction with other topical ophthalmic medications such as beta-blockers, carbonic anhydrase inhibitors, alpha-agonists, cycloplegics, and mydriatics.
If more than one topical ophthalmic medication is being used, the medicines must be administered at least 5 minutes apart.
![Nevanac (Nepafenac) Suspension [Physicians Total Care, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=52fe0332-388a-451c-b759-97e760883837&name=6302.jpg)
![Nevanac (Nepafenac) Suspension [Alcon Laboratories, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=3ad48650-75e3-4c74-9302-01b0088f164e&name=carton.jpg)
Login To Your Free Account